DIGITAL INNOVATION FOR BIOLOGICAL PRODUCTION
Technological and digital innovation
Innovation through digital transformation
The digital transformation affects bioprocesses and the bioprocessing industry just like everything else in our lives. Such transformation holds promises of significant business advantages for the companies. New mindsets, methods, and technology are being introduced at a rapid pace. Digital technologies can mitigate these work environmental challenges by partially automating trivial tasks and generating better decision-making. At the same time, it should be recognized that enabling technologies may introduce potential challenges for users.
Traditionally, biopharma companies have been slow to incorporate digital technologies such as augmented/virtual reality (AR/VR), artificial intelligence (AI), cloud computing, and the IoT into their operations. The COVID-19 pandemic forced companies to prioritize investments in digital innovation more than before and in the wake of this development it is needed to test where and how new technology can and will be used. Testa Center has an authentic production environment for the development, testing, and verification of operational technology, information technology, automation, and all other products and services that help us enhance quality, efficiency, user experience, and usability.
In Testa Center, we interact with researchers and companies working at the intersection of life science, software, and hardware development. We help to bridge the gap between people and technology, as well as between research and commercialization, so that the potential for innovative digital technologies is based on user needs. Closing this gap means that people can work faster and more efficiently with innovative digital technologies and a perceived sense of meaningfulness and self-fulfillment in the process of drug discovery. It also means that new innovations can be tested and verified in a real environment, hence shortening the time-to-market.
Better ways of working
- Silo
- Right of first refusal (IP)
- Pay upfront
- Manual
- Paper
- Closed, on-site only
- DIY or outsource
- Air-gaped
- Compliance first
- Collaboration
- Sharing of knowledge
- As-a-Service
- Automated
- Digital
- Open test-bed, remote digital access
- Gives you a helping hand
- Open data interfaces
- Innovation first
Projects
April 8, 2020
Testa Challenge is an opportunity to verify bio-process technology
Looking for an industrial verification environment for your innovative bio-process technology? Apply to Testa Challenge!
Background
Biological drugs and products are transforming medicine and promise future targeted treatments for a range of conditions. However, for these powerful products to benefit all people in the world, a large number of new technologies and tools that can drastically improve productivity of biological production are needed. New methods, processes and approaches need to be developed in order to accelerate innovation in this area.
Technology or digital projects and companies are invited!
We know that there are countless promising technologies out there. We also know that, as a young technology developing company, it can be a significant threshold to get access to a relevant industrial verification environment. To address this gap, Testa Center now invite to Testa Challenge.
Projects and companies from the technology/digital segments are invited to integrate, test and witness their innovation within a sponsored production workflow at Testa Center. Alongside the production process, participants will be supported by experts and have the possibility to experience their innovation hands on.
We offer
The provided facilities, expertise and fast-tracked application will allow an early evaluation whether the innovation is applicable and successful for the bio-processing industry. The production process will be designed to include approximately five selected technologies and run in Testa Center during October 2020.
What are we looking for?
We welcome all kind of innovative solutions that have the potential to meet the future technology needs within bio-production. Some examples in the area of technology include sensors, separation technology, pumps, etc. and within the digital/data segment, some examples include cloud solutions, VR / AR, AI, data transfer, modeling, automation, smart laboratory tools, etc.
Who can apply?
The call is open for projects and companies from all entities (academic, start-ups, larger companies, and institutes) across Europe. Application opens May 8 2020.
December 2, 2021
Xertified XoT devices to secure life science equipment
It was obvious from the first meeting that there is a case for Xertified to secure vulnerable life science equipment. Promising cyber security improvements in fifteen minutes or less seemed like an interesting promise, stretching what I thought was even possible. One week later we are all much wiser, this is what we learned.
Xertified and Biotage ran a one-week test in the Testa Center to test if their “XoT solution” could improve the cyber security posture of life science equipment. Another goal for the project was to learn about customer demands on cyber security in life sciences.
During the week Xertified and Testa Center ran test cases with the XoT-device using the Cytiva Xcellerex Disposable Reactor 50 liters, the ReadyToProcess Wave25 bioreactor, an ÄKTA ready flux instrument, the Applikon/Getinge Easy Controller 2 tower and bioreactor, as well as a Mettler Toledo IND570 floor scale.
Test and interviews for cyber security insights
Tests were conducted to try out communication, functionality, and to reduce cyber security attack surfaces. The team also conducted interviews with participants and stakeholders to learn about life science and biotech demands on cyber security. A discussion was held with subject matter experts on cyber security implementation, instrumentation development, customers’ feedback, as well as on remote service and maintenance.
Reduced attack surface
The tests revealed that most instruments in this test received cyber security benefits from utilizing the Xertified offering using XoT-devices and management systems.
Universities and small-medium businesses could be the early adopters
From the interviews, it was derived that the typical “big-pharma” customer usually has an IT department with in-house cyber security expertise. It was also found that the “big-pharma” customer normally does not allow for the introduction of new devices after the manufacturing process has been deployed, verified, and in production. The interviews revealed that universities usually are early adopters of new technology and usually work in cyber security risk environments as their lab often gives open access to students and researchers even as they work with forefront research. On the other hand, universities tend to be price sensitive.
The best fit for the XoT solution in life science equipment seems to be to support equipment and instruments that are sold to the small and medium business (SMB) segment. The SMBs usually have a basic to an above-average understanding of cyber security and understand the need for improved security if it comes as a combined or integrated solution.
Other findings
We also found a lot of ideas for new features on the XoT device, the client package, and the management portal that would be beneficial for the life science industry.
The original time plan was adjusted during Tuesday as the RTU (real-time unit), ÄKTA Go, Pure, and Pilot 600 was ruled out from the original test plan due to their network design. Time ran out while we were testing the ReadyToProcess Wave 25, so the results are inconclusive on that specific device.
Improved security in fifteen minutes?
So, did we get the improved cyber security posture in just fifteen minutes per instrument? Not for the first or second instrument, but for the third and fourth, yes, we did!
We also learned about the reasons why very few labs and even fewer process manufacturers allow for public internet access to the control systems, even when the users demand it.
With the learnings from this project, Xertified should soon be able to make it possible for labs to securely use more Internet-connected instruments and services in the labs, by using their XoT technology.
Oktober 7, 2020
Solving the chicken-and-egg problem with technology in bioprocess
Why is it hard for tech and digital innovation companies to brake new ground in the bioprocess market? Proprietary data standards, long product cycles, legacy systems, high investment costs and an intellectual property mine field are just a few of the obstacles for the startups, small and medium enterprises and industry.
Testa Center is committed to lowering these barriers. We work together with innovative actors within the field of bio-process, including the digital and tech sectors. At Testa Center we see the obstacles facing these actors first hand. Bio-process companies often choose the established ways-of-working to lower the project risk as much as possible. Taking in a new and innovative product or service into a bioprocess workflow is considered risky. It’s a chicken-and-egg problem. Established ways-of-working is secure, but innovative products and processes are needed to ensure longevity as a bio-process actor.
Testa Challenge removes barriers for digital and tech innovation
How can we solve this? We believe Testa Challenge is one way to do it. We got the idea for the Testa Challenge in a cross-functional workshop with tech and bio innovation experts. Inspired by concepts like Open Innovation, Hackathons, Co-working/Co-creation and Investor-pitching, we decided to mimic the innovation process in tech and digital industries and put it into a bioprocess context. Testa Challenge is now our event-concept that mixes the best parts of all the innovation concepts above. To keep posted on the outcome of Testa Center, please re-visit our website and follow us in our social media. We will of course share some of our learnings from this innovative approach to solve a problem.
What is happening now? Preparations are now taking place for the first ever Testa Challenge. Participants will arrive to attend the challenge at Testa Center on 19 October 2020. Some participants attend the challenge in person, others online.
The Testa Challenge is a way for Testa Center to facilitate faster verification of innovations, acceleration of industrialization and to secure excellence at the intersection of digital solutions, technology improvements and bioprocess.
Thank you to all participants, financiers and supporters. Together we are making something really exiting!
Make sure to keep track of what is happening at testachallenge.com
February 1, 2023
Xertified x Testa Center White Paper
Testa Center and Xertified have written a white paper together about the XoT Technology™ that Testa Center recently implemented for dedicated access control.
”Being trained as a biochemist I am always nervous that I don’t understand the IT enough for operations in Testa Center and in particular the security aspects. Now however, the instruments that are hooked up to our network are more secure than ever, thanks to our collaboration with Xertified” – Jesper Hedberg, CEO, Testa Center
Click here to read the white paper.
Feel free to contact us if you would like to know more!
December 11, 2019
Rockwell Automation in Testa Center for Pharma 4.0
On the 11th of December we had the pleasure to welcome Felix Langkjaer, Martin Ohlsson, Peter Cullen with entourage, from Rockwell Automaton, for a meeting in Testa Center.
Rockwell Automation an supplier of automation in a broad spectrum of industries. Testa Center is a flexible and open access bio-process R&D facility. Mixing these two in one room gave rise to a lot of very interesting conversations about industry trends, opportunities and challenges.
Some of them where;
- Pharma 4.0, described by Rockwell is happening now! Some of it in Testa Center.
- Traditional Operational Technology is transforming into Information Technology.
- The rapid phase of change in Testa Center offers a opportunity to test and learn for everyone!
If you are interested in Pharma 4.0 you should definitely read Rockwell Automation’s brochure “The factory of the future” now.
If you like to visit Testa Center for a tour you can do it in the virtual tour or by booking a tour!
Thank you very much Rockwell Automation for interesting discussions and for having GE Healthcare in your Partner Program! Let’s work together for “bio-processing solutions ‘for the digital age'”! (source: biopharma-reporter.com)
The Testa Challenge
In October 2020, we ran the first Testa Challenge, a one-week open bioprocess run for technology innovators. Like a hackathon, innovators were asked to solve industry problems related to the themes set up by the Testa Center. Sponsors paid for the food and consumables to give the teams time to focus and spark innovation.
Themes of 2020
Video capturing
Heat pistol on stile bag
Shake flask experiment
Bioreactor run meeting
In-line custom sensor
Analytics was ok!
Very early mornings all week
The upstream process
I have learned a lot. Every step of the process, setting up the columns at a much larger scale is a whole new method. It’s a really good experience, lots of help and fantastic equipment. The team is very kind, helping us with the technical and practical needs